Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

301
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
301
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

226
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
226
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

188
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
188
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

414
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
414
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

314
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
314
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

899
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
899

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life among Indian paediatric patients suffering from constipation: An evaluative study.

Bioinformation·2026
Same author

Benign Keratoses With Inverted Follicular Keratosis-Like Features in a Patient Receiving Ripretinib: A Case Report.

Journal of cutaneous pathology·2026
Same author

Health Effects of Per- and Polyfluoroalkyl Substances.

American family physician·2025
Same author

Case Study of a Comprehensive Team-Based Approach to Increase Colorectal Cancer Screening.

Journal of Appalachian health·2022
Same author

Part I Antimicrobial resistance: Bacterial pathogens of dermatologic significance and implications of rising resistance.

Journal of the American Academy of Dermatology·2022
Same author

Effect of root dentin conditioning using different chelating agents on pushout bond strength of MTA-fillapex and bioroot RCS: An <i>in vitro</i> study.

Journal of conservative dentistry : JCD·2021

Related Experiment Video

Updated: Aug 28, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Tuberculosis: Common Questions and Answers.

Holly Hartman-Adams1, Robert M Gerbo2, Saira George1

  • 1West Virginia University School of Medicine, Morgantown, West Virginia.

American Family Physician
|September 20, 2022
PubMed
Summary

Tuberculosis (TB) affects millions globally, with latent TB infection (LTBI) posing a risk for progression to active disease. Early testing and appropriate treatment are crucial for managing TB and preventing transmission.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Related Experiment Videos

Last Updated: Aug 28, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, causing millions of infections and deaths annually.
  • Latent TB infection (LTBI), an asymptomatic state caused by Mycobacterium tuberculosis, affects millions in the US and can progress to active disease in 5-10% of individuals.
  • Early detection and treatment of LTBI and active TB disease are critical for public health.

Purpose of the Study:

  • To outline current recommendations for testing, diagnosis, and treatment of latent tuberculosis infection (LTBI) and active TB disease.
  • To emphasize the importance of reporting suspected and confirmed cases of TB to health departments.
  • To provide guidance on preferred treatment regimens for LTBI and drug-susceptible TB disease.

Main Methods:

  • Review of U.S. Preventive Services Task Force guidelines for LTBI screening.
  • Description of diagnostic procedures including interferon-gamma release assays, tuberculin skin testing, chest radiography, and sputum collection.
  • Summary of recommended treatment regimens for LTBI and drug-susceptible TB disease.

Main Results:

  • The U.S. Preventive Services Task Force recommends testing individuals at increased risk for LTBI.
  • Periodic retesting of healthcare professionals for LTBI is not recommended due to similar incidence rates to the general population.
  • Reporting of all suspected and confirmed LTBI and TB disease cases is mandatory.

Conclusions:

  • Prompt diagnosis and treatment of LTBI and active TB disease are essential to prevent progression and transmission.
  • Specific treatment regimens are recommended for LTBI and drug-susceptible TB disease.
  • Consultation with TB experts is vital for managing drug-resistant TB cases.